Community of Practice: COVID-19 Updates
Here’s how Natera is helping you in the world of COVID-19
Welcome
For this bimonthly newsletter series, Natera has compiled our perspective on new research and case studies to share with the community.
The complexities of patient care in the transplant and nephrology clinical communities are vast from the effects of the Severe Acute Respiratory Syndrome 2 virus (SARS-CoV-2).
Through this series, we look forward to providing the latest information on novel patient management strategies and commentary from your peers to optimize patient care together.
3rd edition, May 2021
- Editorial: Assessing immune reactions to the COVID-19 vaccine in kidney transplant patients
- Editorial: Natera study of kidney transplant beneficiaries’ immune responses to the COVID-19 vaccine
- Editorial: Changing the norms for how telehealth is provided
DOWNLOAD RESOURCES
May 2021 Update
March 2021 Update
December 2020 Update
LINK RESOURCES
Editorial: Assessing immune reactions to the COVID-19 vaccine in kidney transplant patients
Editorial: Natera study of kidney transplant beneficiaries’ immune responses to the COVID-19 vaccine
Editorial: Changing the norms for how telehealth is provided
Editorial: Views from our Medical Director
A Message from our Medical Directors at Natera, Inc
Part of the Solution: Two new kidney injury tests for COVID-19 patient care
FEATURED CASE STUDY
Featured Case Study: Real-world cfDNA Use in the Era of COVID-19
Transplant Case Study: Transplant Assessment in the Age of COVID-19
Acute Kidney Injury Case Study: Linking Severity of COVID-19 to the APOL1 Gene
Natera wants to thank all the healthcare professionals who have been on the frontlines of this crisis. Your dedication, determination, grit, resilience, and sacrifice over the last few months have been inspiring and invaluable to our community.
We extend our call for stories, research, and experiences to our transplant and nephrology partners so we can continue to learn together and improve patients’ lives during these uncertain times. Please contact prospera@natera.com to discuss with the Natera Clinical Team.
